Adverse Drug Reactions and Drug Safety
Monitoring adverse drug reactions (ADRs) is essential for ensuring drug safety. ADRs, ranging from mild effects to severe toxicity, can result from drug interactions, genetic factors, or dosage errors. Pharmacovigilance systems have evolved to track ADRs post-marketing, enabling early detection of risks. Personalized medicine, through pharmacogenomics, improves drug safety by predicting individual responses to therapies, minimizing ADRs, and optimizing treatment. Regulatory frameworks also play a crucial role in maintaining drug safety.
Related Conference of Adverse Drug Reactions and Drug Safety
June 29-30, 2026
13th International Conference on Recycling & Waste Management
Aix-en-Provence, France
June 29-30, 2026
5th Global Congress on Climate Science and Environmental Change
Paris, Aland Islands
September 14-15, 2026
16th International Conference on Environment and Climate Change
Barcelona, Spain
September 28-29, 2026
5th International Conference and Expo on Medical Toxicology and Applied Pharmacology
Paris, France
October 22-23, 2026
15th International Conference on Climate Change & Environmental Science
Vancouver, Canada
